RNA can be designed to silence, express and edit specific genes, providing a flexible and powerful approach to treating diseases. COVID-19 mRNA vaccines, while an extraordinary accomplishment, have revealed that rapid development and scale-up, as well as access to innovative tech...

Nobel Prize Laureate Dr. Michael Houghton gives closing remarks on the 2020 Genetic Medicine Evolution Revolution Summit hosted by Precision Nanosystems. He covers the new vaccine landscape after COVID-19 and the impact of RNA vaccines.

Ribogreen Assay Training When working with RNA lipid nanoparticles, quantifying RNA is crucial to ensuring quality and for accurate dosing, but encapsulation of RNA within LNPs imposes specific challenges.

Learn from our experts on how to perform PNI’s modifie...

Dr. Andy Geall will walk us through the history and commercial mRNA vaccine landscape, the background to the SAM (self-amplifying mRNA) vaccine platform and non-viral delivery. He will also discuss preclinical data of the application in pandemic influenza, and the translation fro...

We recently had the opportunity to present at the TIDES Digital Week, a global 4-day series of live educational webcasts and downloadable resources providing the latest insights for accelerating oligonucleotide and peptide products to commercial success.  The following video...

Featuring speaker Dr. Yvonne Perrie, this webinar will explore advances in mRNA Vaccine Therapies in the fields of Cancer Immunotherapy and Infectious Diseases. 

Dr. Yvonne Perrie

Professor in Drug Delivery, Str...

Featuring speaker Dr. Justin Richner, this livestream will explore advances in mRNA Vaccine Therapies in the fields of Cancer Immunotherapy and Infectious Diseases. 

Dr. Justin M. Richner
Assistant Professor, Department of Microbio...

3rd annual Nanomedicine Symposium in Midtown New York City July 21, 2018

Martin A. Maier, PhD - Vice President of Research at Alnylam Pharmaceuticals

Discover how nanoparticles can deliver vaccines and elicit immune responses and see some of the latest research on mRNA vaccines and immuno-oncology therapeutics. Share this video with others who are interested in the latest in vaccine research.

2nd Annual Nanomedicines Symposium, July 15th, 2017

To Target or Not to Target: Lessons from RNAi-Based Targeted Lipid Nanoparticles - Dan Peer, Tel-Aviv University

2nd Annual Nanomedicines Symposium, July 15th, 2017, Cambridge MA | Peter Johnson, Field Application Scientist, PNI

2nd Annual Nanomedicines Symposium, July 15th, 2017 Cambridge MA

Derek O’Hagan, Global Head of Vaccine Chemistry and Formulation GSK vaccines Research in Cambridge | 2nd Annual Nanomedicines Symposium, July 15th, 2017

Ray Lockard, VP Pharmaceutical Operations, Precision NanoSystems Inc. | 2nd Annual Nanomedicines Symposium, July 15th, 2017

2nd Annual Nanomedicine Symposium | Ocular Delivery of mRNA - Patrick Baumhof, CureVac AG

Dr. Shyam Garg, Formulation Scientist II, Precision NanoSystems Inc. - 2nd Annual Nanomedicines Symposium

Microfluidics-Based Platform for the Seamless Development of Nano-Sized Delivery Systems for Lipophilic Drugs, Shyam Garg, Precision Nanosystems

2nd Annual Nanomedicine Symposium, July 15th 2017, Cambridge MA | Frank Slack, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School

Nanoparticle Manufacturing: Strategies for De-Risking Early Clinical Manufacture - Ray Lockard, Precision NanoSystems

Dr. Shyam Garg, Formulation Scientist II at Precision NanoSystems Inc.

Kevin Ou, Senior Manager of Pharmaceutical Operations was joined by Mike Bransby from Spectrum Labs

First webinar in a three part series.

Presented by Kevin Ou, Senior Manager of Pharmaceutical Operations at Precision NanoSystems Inc.

Dr. Dominik Witzigmann, University of Basel

Workflow with NanoAssemblr® Transfection Kits

Precision NanoSystems' NanoAssemblr® Spark uses pro...

NanoAssmeblr® Blaze demo

The NanoAssemblr® Blaze is an innovative instrument which offers se...

Keynote Speaker from our Nanomedicines Symposium November 29th, London UK

Ray Schiffelers - Facing the Challenge of Reproducible and Scalable Nanoparticle Production for RNA Delivery - Keynote

Learn how to operate the NanoAssemblr® Benchtop Instrument.

The NanoAssemblr® Benchtop is a revolutionary instrument that offers both reproducibility and ...

From our 2016 Nanomedicines Symposium in LONDON, UK NOVEMBER 29th, 2016

Nanomedicines Symposium, November 29th, 2016 - LONDON UK

Dominik Witzigmann - Targeted DNA Therapeutics- Hepatic Diseases - University of Basel

Nanomedicines Symposium, November 29th, 2016 - LONDON UK

Stephen Hart - Targeted Lipid/Peptide Nanocomplexes for Nucleic Acid Delivery - UCL

Nanomedicine Symposium, November 29th, 2016 - LONDON UK

Carla Prata - Liver Cell Type Tropism of siRNA Lipid-Nanoparticles - Axolabs

Nanomedicines Symposium

Jaroslav Turanek - Veterinary Research Institute, Brno Czech Republic - 

Nanomedicines Symposium, London UK November 29th, 2016

Yvonne Perrie, Strathclyde University - Lab-on-Bench Production of Vaccine Adjuvants

The NanoAssemblr® Blaze is enabling for researchers and drug development programs. The dynamic volume range allows researchers to use the Blaze for nanoparticle discovery, for preclinical toxicology testing, and for early Chemistry, Manufacturi...

Nanomedicines Symposium, November 29, 2016 - LONDON UK

Kirsten Gräser -  Nanoparticles: Application of the Technology at Roche

Nanomedicines Symposium, November 29th, 2016 - London UK

Dimitrios Lamprou - Lipid Formulations: Microfluidics vs Traditional Method - Kent University

Neuro9 Kits: Cellular Transfection

Efficient RNA delivery to neurons via ApoE-mediated cell uptake. Neuro9 nanoparticles mimic th...

The NanoAssemblr® Spark Demo

The NanoAssemblr® Spark uses proprietary microfluidics technolo...

Webinar from Dr. Gaurav Sahay, Assistant Professor, OSU/OHSU College of Pharmacy

The deployment of nanoparticles that can deliver drugs/genes inside cells by exploiting endocytosis has shown tremendous potential for bi...

We provide scientists with an integrated platform of products and support, helping advance innovative nanotechnology solutions for the molecular understanding and treatment of disease. Check ou...

We provide scientists with an integrated platform of products and support, helping advance innovative nanotechnology solutions for the molecular understanding and treatment of disease.

We provide scientists with an integrated platform of products and support, helping advance innovative nanotechnology solutions for the molecular understanding and treatment of disease. Check out more info on the Spark.

2016 Nanomedicines: Materials, Manufacturing & Therapeutic Applications Symposium, July 16th in Seattle, WA

Introductory talk: James Taylor, CEO, Precision NanoSystems (PNI) - Nanomedicines: Materials, Manuf...

NanoAssemblr® Blaze™ Tech Talk during the 2016 PNI Nanomedicines Symposium

NanoAssemblr® Spark™ Tech Talk from 2016 PNI Nanomedicine Symposium

NanoAssemblr® Formulation Kits

NanoAssemblr® Benchtop Tech Talk from 2016 Nanomedicine Symposium

NanoAssemblr® GMP Scale-Up System | Ray Lockard, Precision NanoSystems, Inc.

Liposomes: from Prototype to the Clinic | Norbert Maurer, Transferra Nanosciences

Microfluidics in manufacturing of mRNA Nanomedicines | Heinrich Haas, BioNTech

Targeted mRNA delivery to the Liver for Intracellular Enzyme Replacement Therapy | Pierrot Harvie, PhaseRX

Nanomedicine Symposium

Preparation of nano droplets for ultrasound theranostics by using the NanoAssemblr® - Kazuo Maruyama - Teikyo University

Related Resources:

in situ Interrogation of structured Lipid Particle Formation Processes using Microfludic Mixing Devices | Ben Boyd, Monash University

Improved CRISPR Genome Editing using crRNA:tracrRNA complexes and Cas9 | Ashley Jacobi, IDT

Nanomedicine Symposium

Lipids for Liposomes: Selection, Preparation and Application - Di Bush - Avanti Polar Lipids

Nanomedicine Symposium

Nanoparticle Size Characterization: Tips & Tricks for Light Scattering - Ulf Nobbmann -  Malvern Instruments

Microfluidic-mediated self-assembly of liposomes and polymer nanoparticles expands the strategies available to the formulation scientist for the encapsulation and delivery of hydrophobic compounds. In this webinar Dr. James Taylor and Dr. Shyam Gar...

Dr. Shyh-Dar Li from the University of British Columbia introduced the design, synthesis and fabrication of a self-assembled polymeric nanoparticle system, and the use of which to deliver insoluble anticancer drugs for therapy of tumors in preclini...

Nanomedicines are a promising treatment modality for the targeted delivery and controlled release of therapeutic agents. To fully achieve the potential of nanomedicines there is a need to improve the reproducibility and scalability of production me...

In this webinar, Professor Pieter Cullis from the University of British Columbia will unpack the application of microfluidics for the preparation of "limit-size" lipid nanoparticle systems including liposomes, nanoemulsions and RNA-lipid nanopartic...

In this webinar, Dr. Marc-Andre Dansereau from the Université de Sherbrooke will describe how RNAi was used to better understand how the CCL2 chemokine and its receptor, CCR2, contribute to the development of chronic pain. Although CCR2 has ...

In this webinar, Professor Dan Peer from Tel Aviv University will talk about the application of microfluidics for the preparation of targeted lipid nanoparticles entrapping siRNAs (RNA-tLNPs) directed towards lymphocytes . Special emphasis will be ...

NanoAssemblr® Platform Accelerating the Development of Nanomedicines Microfluidics

Precision NanoSystems’ proprietary Na...